Endoglin (CD105): A powerful therapeutic target on tumor-associated angiogenetic blood vessels

Oncogene

Volumn 22, Issue 43, 2003, Pages 6557-6563

  Fonsatti, Ester ^a   Altomonte, Maresa ^a   Nicotra, Maria Rita ^b   Natali, Pier Giorgio ^c   Maio, Michele ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b CNR   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Angiogenesis; CD105; Endoglin; Endothelial cells; Soluble CD105; Transforming growth factor

Indexed keywords

COMPLEMENTARY DNA; ENDOGLIN; MONOCLONAL ANTIBODY; RNA; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; ANIMAL MODEL; ANTIGEN EXPRESSION; BREAST CANCER; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER THERAPY; COLORECTAL CANCER; ENDOTHELIUM CELL; HEAD AND NECK CANCER; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOLID TUMOR;

ANIMALIA;

EID: 0242708765     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206813     Document Type: Review

References (88)

1. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabéu C and Letarte M. (2000). Hum. Mol. Genet., 9, 1227-1237.
2. Adam PJ, Clesham GJ and Weissberg PL. (1998). Biochem. Biophys. Res. Commun., 247, 33-37.
3. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M and Abe T. (2002). Surgery, 131, S109-S113.
4. Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, Nicotra MR, Cattelan A, Natali PG and Maio M. (1996). Br. J. Cancer, 74, 1586-1591.
5. Balza E, Castellani P, Zijlstra A, Neri D, Zardi L and Siri A. (2001). Int. J. Cancer, 94, 579-585.
6. Barbara NP, Wrana JL and Letarte M. (1999). J. Biol. Chem., 274, 584-594.
7. Bellón T, Corbi A, Lastres P, Calés C, Cebrian M, Vera S, Cheifetz S, Massagué J, Letarte M and Bernabéu C. (1993). Eur. J. Immunol., 23, 2340-2345.
8. Blobe GC, Schiemann WP and Lodish HF. (2000). N. Engl. J. Med., 342, 1350-1358.
9. Botella LM, Sanchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S and Bernabéu C. (2002). Blood, 100, 4001-4010.
10. Bourdeau A, Dumont DJ and Letarte M. (1999). J. Clin. Invest., 104, 1343-1351.
11. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR and Letarte M. (2001). Am. J. Pathol., 158, 2011-2020.
12. Bredow S, Lewin M, Hofmann B, Marecos E and Weissleder R. (2000). Eur. J. Cancer, 36, 675-681.
13. Brekken RA, Li C and Kumar S. (2002). Int. J. Cancer, 100, 123-130.
14. Brewer CA, Setterdahl JJ, Li MJ, Johnston JM, Mann JL and McAsey ME. (2000). Obstet. Gynecol., 96, 224-228.
15. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES and Thorpe PE. (1995). Clin. Cancer Res., 1, 1623-1634.
16. Calabrò L, Fonsatti E, Bellomo G, Alonci A, Colizzi F, Sigalotti L, Altomonte M, Musolino C and Maio M. (2003). J. Cell. Physiol., 194, 171-175.
17. Carmeliet P and Jain RK. (2000). Nature, 407, 249-257.
18. Cheifetz S, Bellón T, Calés C, Vera S, Bernabéu C, Massagué J and Letarte M. (1992). J. Biol. Chem., 267, 19027-19030.
19. Cho SK, Bourdeau A, Letarte M and Zúñiga-Pflücker JC. (2001). Blood, 98, 3635-3642.
20. Choi KS, Bae MK, Jeong JW, Moon HE and Kim KW. (2003). J. Biochem. Mol. Biol., 36, 120-127.
21. Conley BA, Smith JD, Guerrero-Esteo M, Bernabéu C and Vary CP. (2000). Atherosclerosis, 153, 323-335.
22. Cowan PJ, Shinkel TA, Fisicaro N, Godwin JW, Bernabéu C, Almendro N, Ríus C, Lonie AJ, Nottle MB, Wigley PL, Paizis K, Pearse MJ and D'Apice AJ. (2003). Xenotransplantation, 10, 223-231.
23. Dales JP, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O, Lavaut MN, Allasia C and Charpin C. (2003). Am. J. Clin. Pathol., 119, 374-380.
24. Denekamp J. (1990). Cancer Metastasis Rev., 9, 267-282.
25. Diez-Marquez L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa, JM, Lamas S and Bernabéu C. (2002). Biochim. Biophys. Acta, 1587, 36-44.
26. Fernandez-Ruiz E, St-Jacques S, Bellón T, Letarte M and Bernabéu C. (1993). Cytogenet. Cell Genet., 64, 204-207.
27. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG and Maio M. (2001). J. Cell. Physiol., 188, 1-7.
28. Fonsatti E, Jekunen AP, Kairemo KJ, Coral S, Snellman M, Nicotra MR, Natali PG, Altomonte M and Maio M. (2000). Clin. Cancer Res., 6, 2037-2043.
29. Gougos A and Letarte M. (1988). J. Immunol., 141, 1925-1933.
30. Gougos A and Letarte M. (1990). J. Biol. Chem., 265, 8361-8364.
31. Graulich W, Nettelbeck DM, Fischer D, Kissel T and Muller R. (1999). Gene, 227, 55-62.
32. Guerrero-Esteo M, Sanchez-Elsner T, Letamendía A and Bernabéu C. (2002). J. Biol Chem., 211, 29197-29209.
33. Haruta Y and Seon BK. (1986). Proc. Natl. Acad. Sci. USA, 83, 7898-7902.
34. Henriksen R, Gobl A, Wilander E, Oberg K, Miyazono K and Funa K. (1995). Lab. Invest., 73, 213-220.
35. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, Libermann T and Detmar M. (2003). Am. J. Pathol., 162, 575-586.
36. Jonker L and Arthur HM. (2002). Mech. Dev., 110, 193-196.
37. Jovanovic BD, Huang S, Liu Y, Naguib KN and Bergan RC. (2001). Am. J. Pharmacogenomics, 1, 145-152.
38. Krupinski J, Kaluza J, Kumar P, Kumar S and Wang JM. (1994). Stroke, 25, 1794-1798.
39. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM and Bundred N. (1999). Cancer Res., 59, 856-861.
40. Lastres P, Bellón T, Cabañas C, Sanchez-Madrid F, Acevedo A, Gougos A, Letarte M and Bernabéu C. (1992). Eur. J. Immunol., 22, 393-397.
41. Lastres P, Letamendia A, Zhang H, Ríus C, Almendro N, Raab U, López LA, Langa C, Fabra A, Letarte M and Bernabéu C. (1996). J. Cell Biol., 133, 1109-1121.
42. Lastres P, Martin-Perez J, Langa C and Bernabéu C. (1994). Biochem. J., 301, 765-768.
43. Letamendía A, Lastres P, Almendro N, Raab U, Buhring HJ, Kumar S and Bernabéu C. (1998a). Int. J. Cancer, 76, 541-546.
44. Letamendía A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L and Bernabéu C. (1998b). J. Biol. Chem., 273, 33011-33019.
45. Li C, Guo B, Wilson PB, Stewart A, Byrne G, Bundred N and Kumar S. (2000a). Int. J. Cancer, 89, 122-126.
46. Li C, Hampson IN, Hampson L, Kumar P, Bernabéu C and Kumar S. (2000b). FASEB J., 14, 55-64.
47. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB and Wendel DP. (1999). Science, 284, 1534-1537.
48. Liu Y, Jovanovic B, Pins M, Lee C and Bergan RC. (2002). Oncogene, 21, 8272-8281.
49. Lo Pardo C, Altomonte M, Boccuni P, Di Noto R, Vacca C, Maio M and Del Vecchio L. (1997). Kishimoto T, Kikutani H, Von dem K, Borne AEG, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K and Zola H. (eds). Leucocyte Typing VI. White Cell Differentiation Antigens. Garland Publishing, Inc.: New York, London, pp. 711-712.
50. Ma X, Labinaz M, Goldstein J, Millere H, Keon WJ, Letarte M and O'Brien E. (2000). Arterioscler. Thromb. Vasc. Biol., 20, 2546-2552.
51. Maier JAM, Delia D, Thorpe PE and Gasparini G. (1997). Anti-Cancer Drugs, 8, 238-244.
52. Maio M, Altomonte M, Calabrò L and Fonsatti E. (2001). Front. Biosci., 6, D776-D784.
53. Matsuno F, Haruta, Y, Kondo M, Tsai H, Barcos M and Seon BK. (1999). Clin. Cancer Res., 5, 371-382.
54. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ and Berg JN. (1995). Hum. Mol. Genet., 4, 1983-1985.
55. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericakvance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M and Marchuk DA. (1994). Nat. Genet., 8, 345-351.
56. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek HH, Müller R and Adamkiewicz J. (1999). Int. J. Cancer, 81, 568-572.
57. Nettelbeck DM, Miller DW, Jerome V, Zuzarte M, Watkins SJ, Hawkins RE, Muller R and Kontermann RE. (2001). Mol. Ther., 3, 882-891.
58. O'Connell PJ, McKenzie A, Fisicaro N, Rockman SP, Pearse MJ and D'Apice AJF. (1992). Clin. Exp. Immunol., 90, 154-159.
59. Ota TM, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H and Miyazono K. (2002). J. Cell. Physiol., 193, 299-318.
60. Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G and Leone G. (2001). Leuk. Lymphoma, 42, 1195-1206.
61. Pruneri G, Bertolini F, Baldini L, Valentini S, Goldaniga M, Soligo D, Carboni N, Viale G and Lambertenghi-Deliliers G. (2003). Br. J. Haematol., 120, 695-698.
62. Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F and Viale G. (2002). Br. J. Haematol., 118, 817-820.
63. Qu R, Silver MM and Letarte M. (1998). Cell. Tissue Res., 292, 333-343.
64. Rajkumar SV, Mesa RA and Tefferi A. (2002). J. Hematother. Stem Cell Res., 11, 33-47.
65. Ríus C, Smith JD, Almendro N, Langa C, Botella LM, Marchuk DA, Vary CPH and Bernabéu C. (1998). Blood, 92, 4677-4690.
66. Robledo MM, Hidalgo A, Lastres P, Arroyo AG, Bernabéu C, Sanchez-Madrid F and Teixido J. (1996). Br. J. Haematol., 93, 507-514.
67. Roelen BA, van Rooijen MA and Mummery CL. (1997). Dev. Dyn., 209, 418-430.
68. Rokhlin OW, Cohen MB, Kubagawa H, Letarte M and Cooper MD. (1995). J. Immunol., 154, 4456-4465.
69. Sanchez-Elsner T, Botella LM, Velasco B, Langa C and Bernabéu C. (2002). J. Biol. Chem., 217, 43799-43808.
70. Savontaus MJ, Sauter BV, Huang TG and Woo SL. (2002). Gene Therapy, 9, 972-979.
71. Scappaticci FA. (2002). J. Clin. Oncol., 20, 3906-3927.
72. Schimming R and Marme D. (2002). Head Neck, 24, 151-156.
73. Seon BK. (2002). Int. J. Cancer, 99, 310-311.
74. Seon BK, Matsuno F, Haruta Y, Kondo M and Barcos M. (1997). Clin. Cancer Res., 3, 1031-1044.
75. Tabata M, Kondo M, Haruta Y and Seon BK. (1999). Int. J. Cancer, 82, 737-742.
76. Takahashi N, Haba A, Matsuno F and Seon BK. (2001a). Cancer Res., 61, 7846-7854.
77. Takahashi N, Kawanishi-Tabata R, Haba A, Tabata M, Haruta Y, Tsai H and Seon BK. (2001b). Clin. Cancer Res., 7, 524-532.
78. Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y and Wada H. (2002). Cancer Res., 62, 7124-7129.
79. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K and Wada H. (2001). Clin. Cancer Res., 7, 3410-3415.
80. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R. Li M, Ishikawa S and Wada H. (2003). Lung Cancer, 39, 289-296.
81. Urness LD, Sorensen LK and Li DY. (2000). Nat. Genet., 26, 328-331.
82. van den Driesche S, Mummery CL and Westermann CJ. (2003). Cardiovasc. Res., 58, 20-31.
83. Velasco B, Ramirez JR, Relloso M, Li C, Kumar S, Lopez-Bote JP, Perez-Barriocanal F, Lopez-Novoa JM, Cowan PJ, D'Apice AJ and Bernabéu C. (2001). Gene Therapy, 8, 897-904.
84. Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J and Hunter RD. (1993). Int. J. Cancer, 54, 363-370.
85. Wang JM, Kumar S, Pye D, Haboubi N and Al-Nakib L. (1994). J. Natl. Cancer Inst., 86, 386-388.
86. Wikstrom P, Lissbrant IF, Stattin P, Egevad L and Bergh A. (2002). Prostate, 51, 268-275.
87. Wong SH, Hamel L, Chevalier S and Philip A. (2000). Eur. J. Biochem., 267, 5550-5560.
88. Zhu HJ and Burgess AW. (2001). Mol. Cell. Biol. Res. Commun., 4, 321-330.